SV
Savara
SVRA·NASDAQAustin TXFounded 200825 employees
Micro CapbiotechPublicRespiratoryRare Disease
Platform: Molgramostim PAP
Market Cap
$0.2B
All Drugs
2
Clinical Trials
2
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (SVRA)
Loading SVRA stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Capibrutinib | SVR-3695 | Phase 3 | 1 | APOC3 | PompeHNSCC | ||
| Sovaglumide | SVR-401 | Phase 1/2 | 1 | JAK1 | UC |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (1)